Speaker illustration

Doctor Kim Bouillon

French National Agency for Medicines and Health Products Safety (ANSM), Saint Denis (France)

Short-term risk of haemorrhage during heparin bridging at initiation of vitamin K antagonist therapy in patients with non-valvular atrial fibrillation managed in ambulatory care

Event: ESC CONGRESS 2016

Topic: Atrial fibrillation (AF)

Session: Antithrombotic therapy in atrial fibrillation 1

Thumbnail

This platform is supported by

logo Novo Nordisk